Status:
COMPLETED
Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18-95 years
Brief Summary
Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients who have recently been diagnosed with hypertension
- Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.
- Exclusion criteria:
- None (according to investigator)
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
670 Patients enrolled
Trial Details
Trial ID
NCT00879411
Start Date
April 1 2009
Last Update
March 28 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.